Next Article in Journal
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
Next Article in Special Issue
Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration
Previous Article in Journal
Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results
Previous Article in Special Issue
Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(2), 187; https://doi.org/10.3390/pharmaceutics16020187
Action Date Notes Link
article pdf uploaded. 28 January 2024 12:04 CET Version of Record https://www.mdpi.com/1999-4923/16/2/187/pdf-vor
article supplementary file uploaded. 28 January 2024 12:04 CET - https://www.mdpi.com/1999-4923/16/2/187#supplementary
article xml file uploaded 30 January 2024 07:38 CET Original file -
article xml uploaded. 30 January 2024 07:38 CET Update -
article pdf uploaded. 30 January 2024 07:38 CET Updated version of record https://www.mdpi.com/1999-4923/16/2/187/pdf-vor
article html file updated 30 January 2024 07:40 CET Original file -
article xml file uploaded 6 February 2024 01:41 CET Update -
article xml uploaded. 6 February 2024 01:41 CET Update https://www.mdpi.com/1999-4923/16/2/187/xml
article pdf uploaded. 6 February 2024 01:41 CET Updated version of record https://www.mdpi.com/1999-4923/16/2/187/pdf
article html file updated 6 February 2024 01:42 CET Update https://www.mdpi.com/1999-4923/16/2/187/html
Back to TopTop